Swedish Orphan Biovitrum AB (SOBIN) Stock Forecast & Price Target
SOBIN Analyst Ratings
Strong Buy
3Buy1Hold0Sell
Based on 4 analysts giving stock ratings to Swedish Orphan Biovitrum AB in the past 3 months
SOBIN Stock 12 Month Forecast
Average Price Target
MXN 1,084.37▲(20.02% Upside)Based on 4 Wall Street analysts offering 12 month price targets for Swedish Orphan Biovitrum AB in the last 3 months. The average price target is MXN 1,084.37 with a high forecast of MXN 1,148.16 and a low forecast of MXN 1,014.21. The average price target represents a 20.02% change from the last price of MXN 903.50.
Past 12 Months12 Month ForecastJan2026Oct2026
HighMXN 1.15K
AverageMXN 1.08K
LowMXN 1.01K
Highest Price TargetHighestMXN 1,148.16Average Price TargetMXN 1,084.37Lowest Price TargetLowestMXN 1,014.21
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Mitchell Kapoor | H.C. Wainwright | MXN 1,148.16 | buy | 27.08%Upside | Reiterated | 11/02/26 | ||
| Filip Wiberg | Pareto | MXN 1,014.21 | buy | 12.25%Upside | Upgraded | 10/27/26 | ||
| Mattias Haggblom | Nordea Markets | ― | hold | ― | Downgraded | 10/22/26 | ||
| Harry Gillis | Berenberg Bank | MXN 1,071.62→MXN 1,090.75 | buy | 20.73%Upside | Reiterated | 10/19/26 | ||
| Emmanuel Papadakis | Deutsche Bank | MXN 937.66→MXN 985.50 | buy | 9.08%Upside | Reiterated | 07/21/26 | ||
| James Gordon CFA | Barclays | MXN 899.39→MXN 1,014.21 | buy | 12.25%Upside | Reiterated | 07/03/26 | ||
| Jon Berggren | Kepler Capital | MXN 669.76 | buy | -25.87%Downside | Reiterated | 04/29/26 | ||
 Gonzalo ArtiachNot Ranked | Danske Bank | ― | hold | ― | Downgraded | 02/19/26 | ||
| Kirsty Ross Stewart | Exane BNP Paribas | MXN 908.96 | buy | 0.60%Upside | Upgraded | 02/10/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Mitchell Kapoor | 11/02/26 | MXN 1,148.16 | buy | 27.08%Upside | Reiterated | H.C. Wainwright | ||
| Filip Wiberg | 10/27/26 | MXN 1,014.21 | buy | 12.25%Upside | Upgraded | Pareto | ||
| Mattias Haggblom | 10/22/26 | ― | hold | ― | Downgraded | Nordea Markets | ||
| Harry Gillis | 10/19/26 | MXN 1,071.62→MXN 1,090.75 | buy | 20.73%Upside | Reiterated | Berenberg Bank | ||
| Emmanuel Papadakis | 07/21/26 | MXN 937.66→MXN 985.50 | buy | 9.08%Upside | Reiterated | Deutsche Bank | ||
| James Gordon CFA | 07/03/26 | MXN 899.39→MXN 1,014.21 | buy | 12.25%Upside | Reiterated | Barclays | ||
| Jon Berggren | 04/29/26 | MXN 669.76 | buy | -25.87%Downside | Reiterated | Kepler Capital | ||
| Gonzalo ArtiachNot Ranked | 02/19/26 | ― | hold | ― | Downgraded | Danske Bank | ||
| Kirsty Ross Stewart | 02/10/26 | MXN 908.96 | buy | 0.60%Upside | Upgraded | Exane BNP Paribas |
Stocks with the Highest Top Analyst Consensus in the General Sector
Best Analysts Covering Swedish Orphan Biovitrum AB
3 Months
Success Rate16/22 ratings generated profit
73%
Average Return
+6.76%
Copying Harry Gillis's trades and holding each position for 3 Months would result in 72.73% of your transactions generating a profit, with an average return of +6.76% per trade.
1 Year
Success Rate7/7 ratings generated profit
100%
Average Return
+37.69%
Copying Jon Berggren's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +37.69% per trade.
2 Years
Success Rate7/7 ratings generated profit
100%
Average Return
+45.53%
Copying Jon Berggren's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +45.53% per trade.
SOBIN Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 10 | 10 | 10 | 9 | 6 |
| Hold | 1 | 1 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 11 | 11 | 10 | 10 | 7 |
In the current month, SOBIN has received 6 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. SOBIN average Analyst price target in the past 3 months is 1,084.37.
SOBIN Financial Forecast
High$14.01
Consensus$12.74
Low$11.24
SOBIN Earnings Forecast
Next quarter’s earnings estimate for SOBIN is $12.74 with a range of $11.24 to $14.01. The previous quarter’s EPS was $12.86. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
High$19.1B
Consensus$18.5B
Low$17.6B
SOBIN Sales Forecast
Next quarter’s sales forecast for SOBIN is $18.49B with a range of $17.56B to $19.10B. The previous quarter’s sales results were $17.53B. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.
SOBIN Stock Forecast FAQ
What is MX:SOBIN’s average 12-month price target, according to analysts?
Based on analyst ratings, Swedish Orphan Biovitrum AB’s 12-month average price target is $1,084.37.
What is MX:SOBIN’s upside potential, based on the analysts’ average price target?
Swedish Orphan Biovitrum AB has 20.02% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Swedish Orphan Biovitrum AB a Buy, Sell or Hold?
Swedish Orphan Biovitrum AB has a consensus rating of Strong Buy, which is based on 3 buy ratings, 1 hold ratings and 0 sell ratings.
What is Swedish Orphan Biovitrum AB’s share price target?
The average share price target for Swedish Orphan Biovitrum AB is $1,084.37. This is based on 4 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is $1,148.16, and the lowest forecast is $1,014.21. The average share price target represents a 20.02% increase from the current price of $903.5.
What do analysts say about Swedish Orphan Biovitrum AB?
Swedish Orphan Biovitrum AB’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Street analysts.
How can I buy shares of Swedish Orphan Biovitrum AB?
To buy shares of MX:SOBIN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
